CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore patent oppositions filed by Lederer & Keller Patentanwalte Partnerschaft Mbb against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Last updated on: Jul 31, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Use Of Anti-Pd-1 Antibody In The Treatment Of Patients With Colorectal CancerBRISTOL MYERS SQUIBBJul 26, 2022
Assays For Determining Plasma Kallikrein System BiomarkersDYAXJun 23, 2021
Two-Phase Fermentation Process For The Production Of An Organic CompoundISOBIONICSJun 4, 2021
Pharmaceutical Composition Comprising Brivaracetam And Lacosamide With Synergistic Anticonvulsant EffectUCB PHARMAMay 3, 2021
Compositions For Improving Cell Viability And Methods Of Use ThereofAMYLYX PHARMACEUTICALSJan 12, 2021
Treating Infections With Ceftolozane/Tazobactam In Subjects Having Impaired Renal FunctionMERCK SHARP & DOHMEDec 21, 2020
Vilanterol FormulationsARVEN ILAC SANAYI VE TICARETOct 20, 2020
Dry Powder Formulations Comprising VilanterolARVEN ILAC SANAYI VE TICARETOct 13, 2020
Amorphous Lercanidipine HydrochlorideRECORDATI INDUSTRIA CHIMICA E FARMACEUTICAJul 8, 2020
Particle Containing At Least A Volatile Substance And Process For Its PreparationERBERJun 2, 2020

Top competitors of Lederer & Keller Patentanwalte Partnerschaft Mbb

List of top competitors of Lederer & Keller Patentanwalte Partnerschaft Mbb based on patent oppositions.